(Reuters) -Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a ...

Investment bankers are gearing up for a pickup in dealmaking activity in global equity capital markets this year, buoyed by a ...

India's record-breaking capital-raising spree will continue in 2025 given the strong pipeline of firms looking to go public, ...

Bloks’ Hong Kong initial public offering Friday was 6,000 times oversubscribed and wildly popular after trading began, giving ...

The startup world begins 2025 on a decidedly more upbeat note than it did the previous year. The renewed optimism is in part ...

IPO market could be the biggest in 10 years or more. Here are just eight of them that could be absolutely out-of-the-park ...

Online fast-fashion retailer Shein is aiming to list in London in the first half of the year, according to two sources with ...

GCash, the biggest fintech platform in the Philippines, has picked banks to work on an initial public offering that could ...

Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...

Metsera has filed for an initial public offering. The clinical-stage biopharmaceutical company submitted a registration statement to regulators on Friday, saying it intends to list under the ticker ...

Blackstone (BX) is mulling strategic options, including a sale, for mobile app marketing provider Liftoff that could value the company at over ...

Medical technology firm Brainlab AG has asked for bank proposals for its potential initial public offering in Frankfurt, ...